CD19 and neoplasm: IHC results indicated a significant increase in the percentage of CD4+T cells (Figures 5G, H), CD8+T cells (Figures 5I, J), and CD19+B cells (Figures 5K, L) in the tumor sections of 10 μM CBD-treated mice as compared to the vehicle counterparts.